NYSE:RBOT Vicarious Surgical (RBOT) Stock Price, News & Analysis → AI Cracks Open Largest Untapped Energy Reserve on Earth (From Banyan Hill Publishing) (Ad) Free RBOT Stock Alerts $0.38 -0.01 (-2.59%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$0.35▼$0.3850-Day Range$0.33▼$0.6452-Week Range$0.20▼$2.47Volume393,349 shsAverage Volume692,044 shsMarket Capitalization$65.78 millionP/E RatioN/ADividend YieldN/APrice Target$0.67 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Vicarious Surgical alerts: Email Address Vicarious Surgical MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside79.7% Upside$0.67 Price TargetShort InterestBearish2.96% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$21,046 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.42) to ($0.41) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.05 out of 5 starsMedical Sector737th out of 947 stocksSurgical Appliances & Supplies Industry16th out of 18 stocks 3.0 Analyst's Opinion Consensus RatingVicarious Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.67, Vicarious Surgical has a forecasted upside of 79.7% from its current price of $0.37.Amount of Analyst CoverageVicarious Surgical has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.96% of the outstanding shares of Vicarious Surgical have been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in Vicarious Surgical has recently increased by 11.88%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldVicarious Surgical does not currently pay a dividend.Dividend GrowthVicarious Surgical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RBOT. Previous Next 1.1 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 1 article on an average week.Search Interest17 people have searched for RBOT on MarketBeat in the last 30 days. This is an increase of 113% compared to the previous 30 days.MarketBeat Follows6 people have added Vicarious Surgical to their MarketBeat watchlist in the last 30 days. This is an increase of 20% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $21,046.00 in company stock.Percentage Held by Insiders14.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions65.16% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Vicarious Surgical are expected to grow in the coming year, from ($0.42) to ($0.41) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vicarious Surgical is -0.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vicarious Surgical is -0.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVicarious Surgical has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyMy next big prediction isn’t a predictionI believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.Click here now to sign up About Vicarious Surgical Stock (NYSE:RBOT)Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Read More RBOT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RBOT Stock News HeadlinesMarch 12, 2024 | msn.comRobotic interface masters a soft touchMarch 7, 2024 | investing.comVicarious Surgical earnings beat by $0.06, revenue was in line with estimatesMarch 18, 2024 | Weiss Ratings (Ad)The ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …March 6, 2024 | seekingalpha.comVicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call TranscriptMarch 5, 2024 | au.finance.yahoo.comQ4 2023 Vicarious Surgical Inc Earnings CallMarch 5, 2024 | finance.yahoo.comVicarious Surgical Inc. (NYSE:RBOT) Q4 2023 Earnings Call TranscriptMarch 5, 2024 | markets.businessinsider.comVicarious Surgical (RBOT) Gets a Hold from BTIGMarch 4, 2024 | marketwatch.comVicarious Surgical Chairman David Styka ResignsMarch 18, 2024 | Monument Traders Alliance (Ad)Make This $3 Trade the Instant the Opening Bell RingsSince the birth of Wall Street, one simple rule has remained the same.... Buy stocks that are cheap....When they’re on sale…. And when nobody else is looking…March 4, 2024 | businesswire.comVicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 22, 2024 | benzinga.comVicarious Surgical Stock (NYSE:RBOT), Short Interest ReportFebruary 20, 2024 | finance.yahoo.comVicarious Surgical to Participate in TD Cowen’s 44th Annual Healthcare ConferenceFebruary 20, 2024 | businesswire.comVicarious Surgical to Participate in TD Cowen's 44th Annual Healthcare ConferenceFebruary 17, 2024 | finance.yahoo.comRBOT Apr 2024 2.500 putFebruary 12, 2024 | finance.yahoo.comVicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024February 2, 2024 | msn.comSurgical robot invented at UNL arrives at International Space StationJanuary 31, 2024 | msn.comA Comprehensive Guide on Development to Impact of Surgical RobotsJanuary 29, 2024 | msn.comVicarious Surgical appoints Randy Clark as PresidentJanuary 29, 2024 | finance.yahoo.comVicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company PresidentDecember 28, 2023 | benzinga.comVicarious Surgical Stock (NYSE:RBOT) Dividends: History, Yield and DatesDecember 5, 2023 | benzinga.comVicarious Surgical Stock (NYSE:RBOT), Analyst Ratings, Price Targets, PredictionsNovember 27, 2023 | finance.yahoo.comIs Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?November 15, 2023 | msn.comCanaccord cuts Vicarious Surgical to hold, cites timelines delaysNovember 15, 2023 | finance.yahoo.comVicarious delays surgical robot as integration challenges, R&D cuts slow developmentNovember 15, 2023 | bizjournals.comVicarious Surgical makes 'significant' headcount cuts in 2nd round of layoffs this yearNovember 15, 2023 | markets.businessinsider.comPiper Sandler Keeps Their Hold Rating on Vicarious Surgical (RBOT)November 15, 2023 | finance.yahoo.comVicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare ConferenceSee More Headlines Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/04/2024Today3/18/2024Next Earnings (Estimated)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:RBOT CUSIPN/A CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees3Year FoundedN/APrice Target and Rating Average Stock Price Target$0.67 High Stock Price Target$1.00 Low Stock Price Target$0.40 Potential Upside/Downside+77.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-71,070,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-82.61% Return on Assets-63.88% Debt Debt-to-Equity RatioN/A Current Ratio13.87 Quick Ratio13.87 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.56 per share Price / Book0.67Miscellaneous Outstanding Shares174,889,000Free Float149,128,000Market Cap$65.78 million OptionableOptionable Beta1.23 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key CompetitorsCollPlant BiotechnologiesNASDAQ:CLGNMilestone ScientificNYSE:MLSSReWalk RoboticsNASDAQ:LFWDAltitude AcquisitionNASDAQ:ALTUNutribandNASDAQ:NTRBView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 575,607 shares on 3/11/2024Ownership: 2.509%Adam David SachsSold 28,282 sharesTotal: $10,181.52 ($0.36/share)Sammy KhalifaSold 22,625 sharesTotal: $8,145.00 ($0.36/share)William John KellySold 7,555 sharesTotal: $2,719.80 ($0.36/share)Vanguard Group Inc.Bought 575,607 shares on 2/15/2024Ownership: 3.447%View All Insider TransactionsView All Institutional Transactions RBOT Stock Analysis - Frequently Asked Questions Should I buy or sell Vicarious Surgical stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" RBOT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RBOT, but not buy additional shares or sell existing shares. View RBOT analyst ratings or view top-rated stocks. What is Vicarious Surgical's stock price target for 2024? 4 brokers have issued twelve-month target prices for Vicarious Surgical's shares. Their RBOT share price targets range from $0.40 to $1.00. On average, they predict the company's share price to reach $0.67 in the next year. This suggests a possible upside of 79.7% from the stock's current price. View analysts price targets for RBOT or view top-rated stocks among Wall Street analysts. How have RBOT shares performed in 2024? Vicarious Surgical's stock was trading at $0.3667 at the beginning of 2024. Since then, RBOT shares have increased by 1.2% and is now trading at $0.3710. View the best growth stocks for 2024 here. When is Vicarious Surgical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our RBOT earnings forecast. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc (NYSE:RBOT) released its earnings results on Monday, March, 4th. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.05. During the same period last year, the firm posted ($0.16) EPS. Who are Vicarious Surgical's major shareholders? Vicarious Surgical's stock is owned by many different retail and institutional investors. Top institutional shareholders include DDD Partners LLC (5.20%), Vanguard Group Inc. (3.45%), Vanguard Group Inc. (2.51%), Northern Trust Corp (0.46%), Charles Schwab Investment Management Inc. (0.20%) and Barclays PLC (0.11%). Insiders that own company stock include Adam David Sachs, John Mazzola, June Morris, Philip Liang, Sammy Khalifa, Ventures V LP Khosla and William John Kelly. View institutional ownership trends. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RBOT) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.